We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Annual update of Public Health England’s e-cigarette evidence review by leading independent tobacco experts.
Regulatory Policy Committee opinion on DHSC’s Tobacco and Vapes Bill IA
(Merck Sharp & Dohme Ltd) Study showed failure to reduce major vascular events and increase in non-fatal serious adverse events – class 2 action within 48 hours. (EL (13)A/02)
Advice for Retailers and Producers
Statutory instruments which have been laid and identified as having impacts on local authorities.
Doses of theophylline, fluvoxamine, caffeine, coumarins including warfarin and the antipsychotics clozapine and olanzapine may have to be altered.
Draft version of the statutory instrument to ban the sale and supply of disposable vapes in England.
Seeks views on how effective the tobacco legislation that came into force between 2010 and 2016 has been.
Submission of notifications for Northern Ireland under article 20 of directive 2014/40/EU.
There is an obligation on the manufacturers and importers of electronic cigarettes to submit a notification of such products they intend to market.
Risks of Nicobrevin outweigh any benefits.
Screening for lung disease is not common in drug and alcohol treatment services but Lambeth has set up a lung health clinic in its CDAT team.
The study found no clear evidence that varenicline was associated with an increased risk of fatal or non-fatal self-harm.
A call for evidence seeking information on a range of themes about children and vaping (using an e-cigarette) to inform evidence-based policy decisions.
This Public Assessment Report (PAR) covers the assessment of the proposal to add three new pack sizes (3, 4 & 6 cannisters) to the licence for Nicorette QuickMist 1mg/spray mouthspray and Nicorette QuickMist Smart T…
This command paper sets out the proposed actions the government will take to tackle smoking and youth vaping.
Guidelines explaining the advertising restrictions on e-cigarettes and re-fill containers required by UK law.
This document explains the Down’s syndrome screening quality assurance support service (DQASS) and how to use it.
Advice for commissioners, service providers and mental health trusts providing care to NHS patients who use electronic cigarettes.
A summary of recent letters and notifications sent to healthcare professionals about medicines, and a patient safety alert on mexiletine hydrochloride.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).